Target type: molecularfunction
Binding to an immunoglobulin of the IgE isotype. [GOC:add, ISBN:0781735149]
Immunoglobulin E (IgE) binding is a complex molecular interaction that plays a crucial role in allergic responses. IgE, a type of antibody, is produced by plasma cells upon sensitization to an allergen. It binds with high affinity to its cognate receptor, FcεRI, which is expressed on the surface of mast cells, basophils, and some eosinophils.
This binding event triggers a cascade of intracellular signaling events that ultimately lead to the release of inflammatory mediators such as histamine, leukotrienes, and cytokines. These mediators are responsible for the characteristic symptoms of allergic reactions, including sneezing, itching, swelling, and airway constriction.
The molecular basis of IgE binding to FcεRI involves several key features. First, IgE possesses a unique structure that allows it to interact with FcεRI with high affinity. This high affinity is due to a combination of electrostatic interactions, hydrogen bonds, and van der Waals forces. Second, FcεRI is a multimeric receptor composed of four subunits (α, β, γ2). The α chain binds to IgE, while the β and γ2 chains are involved in signaling.
The interaction between IgE and FcεRI is highly specific and involves a precise fit between the two molecules. This specificity is critical for ensuring that IgE does not bind to other receptors or molecules in the body.
The molecular function of IgE binding is therefore not limited to a single event. It is a complex interplay of events involving specific receptor-ligand interactions, conformational changes, and signal transduction pathways that ultimately result in the release of inflammatory mediators and the manifestation of allergic symptoms.'
"
Protein | Definition | Taxonomy |
---|---|---|
Galectin-3 | A galectin-3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17931] | Homo sapiens (human) |
Low affinity immunoglobulin epsilon Fc receptor | A low affinity immunoglobulin epsilon Fc receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P06734] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
lactose | beta-lactose : The beta-anomer of lactose. lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. | lactose | |
methyl alpha-d-galactopyranoside | methyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position. methyl-galactopyranoside: structure in first source | alpha-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
methyl beta-galactoside | methyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position. methyl beta-galactoside: RN given refers to (beta-D)-isomer methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group. | beta-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
thiodigalactoside | thiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer | ||
methyl lactoside | beta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position. | disaccharide derivative; methyl glycoside | |
3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide | 3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)N-hydroxy-5-methylhexanamide: structure in first source | ||
n-acetyllactosamine | N-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-acetyllactosamine: RN given refers to D-isomer | beta-D-Galp-(1->4)-D-GlcpNAc | |
galactose | alpha-D-galactoside : Any D-galactoside having alpha-configuration at its anomeric centre. | D-galactopyranose | mouse metabolite |
galactal | galactal: RN given refers to cpd with unspecified isomeric designation; structure | anhydrohexose; glycal | |
batimastat | batimastat : A secondary carboxamide resulting from the formal condensation of the carboxy group of (2S,3R)-5-methyl-3-{[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}-2-[(thiophen-2-ylsulfanyl)methyl]hexanoic acid with the amino group of hydroxylamine. It a broad-spectrum matrix metalloprotease inhibitor. batimastat: structure given in first source; a synthetic matrix metalloproteinase inhibitor | hydroxamic acid; L-phenylalanine derivative; organic sulfide; secondary carboxamide; thiophenes; triamide | angiogenesis inhibitor; antineoplastic agent; matrix metalloproteinase inhibitor |
gi 129471 | GI 129471: metalloprotease inhibitor that blocks TNF-alpha secretion; structure given in first source | ||
pf-2545920 |